Colgate Palmolive Co (CL) stock
CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 9/3034% above fair value
$97.90−0.10 (-0.10%)
Close on Nov 12, 2026Market cap $77.82BP/E 38.4Yield 2.12%
Colgate Palmolive total assets
Total assets on the balance sheet at the end of each period.
Colgate Palmolive's total assets was $16.74B at Sep 30, 2026. For fiscal 2025 it was $16.33B, up 1.8% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is $16.39B in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.33B | +1.8% |
| FY2024 | Dec 31, 2024 | $16.05B | -2.1% |
| FY2023 | Dec 31, 2023 | $16.39B | +4.2% |
| FY2022 | Dec 31, 2022 | $15.73B | +4.6% |
| FY2021 | Dec 31, 2021 | $15.04B | -5.5% |
| FY2020 | Dec 31, 2020 | $15.92B | +5.9% |
| FY2019 | Dec 31, 2019 | $15.03B | +23.6% |
| FY2018 | Dec 31, 2018 | $12.16B | -4.1% |
| FY2017 | Dec 31, 2017 | $12.68B | +4.6% |
| FY2016 | Dec 31, 2016 | $12.12B | +1.6% |
| FY2015 | Dec 31, 2015 | $11.94B | -11.2% |
| FY2014 | Dec 31, 2014 | $13.44B | -3.9% |
| FY2013 | Dec 31, 2013 | $13.99B | +4.4% |
| FY2012 | Dec 31, 2012 | $13.39B | +5.3% |
| FY2011 | Dec 31, 2011 | $12.72B | +13.9% |
| FY2010 | Dec 31, 2010 | $11.17B | +0.3% |
| FY2009 | Dec 31, 2009 | $11.13B | +11.6% |
| FY2008 | Dec 31, 2008 | $9.98B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $16.74B | -4.4% |
| Q2 FY2026 | Jun 30, 2026 | $16.79B | -3.9% |
| Q1 FY2026 | Mar 31, 2026 | $16.61B | -0.2% |
| Q4 FY2025 | Dec 31, 2025 | $16.33B | +1.8% |
| Q3 FY2025 | Sep 30, 2025 | $17.51B | +4.4% |
| Q2 FY2025 | Jun 30, 2025 | $17.47B | +6.0% |
| Q1 FY2025 | Mar 31, 2025 | $16.65B | +0.5% |
| Q4 FY2024 | Dec 31, 2024 | $16.05B | -2.1% |
| Q3 FY2024 | Sep 30, 2024 | $16.77B | +4.6% |
| Q2 FY2024 | Jun 30, 2024 | $16.48B | +1.6% |
| Q1 FY2024 | Mar 31, 2024 | $16.57B | +2.5% |
| Q4 FY2023 | Dec 31, 2023 | $16.39B | +4.2% |
| Q3 FY2023 | Sep 30, 2023 | $16.04B | -1.5% |
| Q2 FY2023 | Jun 30, 2023 | $16.23B | +3.3% |
| Q1 FY2023 | Mar 31, 2023 | $16.17B | +2.9% |
| Q4 FY2022 | Dec 31, 2022 | $15.73B | +4.6% |
| Q3 FY2022 | Sep 30, 2022 | $16.29B | +2.6% |
| Q2 FY2022 | Jun 30, 2022 | $15.71B | -1.8% |
| Q1 FY2022 | Mar 31, 2022 | $15.72B | -0.5% |
| Q4 FY2021 | Dec 31, 2021 | $15.04B | -5.5% |
| Q3 FY2021 | Sep 30, 2021 | $15.88B | +2.7% |
| Q2 FY2021 | Jun 30, 2021 | $16.00B | +5.7% |
| Q1 FY2021 | Mar 31, 2021 | $15.80B | +4.9% |
| Q4 FY2020 | Dec 31, 2020 | $15.92B | +5.9% |
| Q3 FY2020 | Sep 30, 2020 | $15.47B | +2.9% |
| Q2 FY2020 | Jun 30, 2020 | $15.14B | +15.1% |
| Q1 FY2020 | Mar 31, 2020 | $15.07B | +17.0% |
| Q4 FY2019 | Dec 31, 2019 | $15.03B | +23.6% |
| Q3 FY2019 | Sep 30, 2019 | $15.03B | +19.5% |
| Q2 FY2019 | Jun 30, 2019 | $13.15B | +4.0% |
| Q1 FY2019 | Mar 31, 2019 | $12.88B | -2.0% |
| Q4 FY2018 | Dec 31, 2018 | $12.16B | -4.1% |
| Q3 FY2018 | Sep 30, 2018 | $12.57B | -1.6% |
| Q2 FY2018 | Jun 30, 2018 | $12.65B | +0.6% |
| Q1 FY2018 | Mar 31, 2018 | $13.14B | +5.6% |
| Q4 FY2017 | Dec 31, 2017 | $12.68B | +4.6% |
| Q3 FY2017 | Sep 30, 2017 | $12.78B | – |
| Q2 FY2017 | Jun 30, 2017 | $12.58B | – |
| Q1 FY2017 | Mar 31, 2017 | $12.45B | – |
| Q4 FY2016 | Dec 31, 2016 | $12.12B | – |
See a number that looks wrong?